Changes in bone biomarkers in antiretroviral naïve...

Changes in bone biomarkers in antiretroviral naïve HIV-infected men randomised to nevirapine/lopinavir/ritonavir (NVP/LPV/R) or zidovudine/lamivudine/lopinavir/ritonavir (AZT/3TC/LPV/R) help explain limited loss of bone mineral density over first 12 months

B.F. Murray⁎, M.G. van Vonderen, P.W. Mallon, P. Doran, M.A. van Agtmael, S.A. Danner, P. Lips, P. Reiss
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2012.02.525
File:
PDF, 77 KB
english, 2012
Conversion to is in progress
Conversion to is failed